Clinical trial
Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1
NCT00040040 · National Institute on Drug Abuse (NIDA), NIH · Unknown status
Key facts
| NCT number | NCT00040040 |
|---|---|
| Title | Assessment of Potential Interactions Between Methamphetamine and Bupropion - 1 |
| Official title | Double-Blind, Placebo-Controlled Assessment of Potential Interactions Between IV Methamphetamine and Oral Bupropion |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Collaborators | University of California, Los Angeles |
| Status | Unknown status |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Amphetamine-Related Disorders |
| Intervention type | Drug |
| Interventions | Bupropion |
| Enrollment | 20 |
| Start date | Jun 1, 2002 |
| Completion | Sep 1, 2003 |
| First posted | Jun 18, 2002 |
| Last update posted | Jan 11, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: